Low Dose Naltrexone (LDN) for Fibromyalgia: A Pain & Fatigue Relief Retatrutide, an experimental weight loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam A small study published in JAMA Ophthalmology analyzed data from nine patients who developed severe vision issues, including sudden blindness, while taking semaglutide (Wegovy, Ozempic) or tirzepatide (Mounjaro, Zepbound). Whilst correlation is retatrutide clinical trial saudi arabia Clinical trial results for retatrutide, Eli Lilly's next weight loss drug, Novo Nordisk announces that CVS Caremark, the country's largest PBM, has decided Wegovy will be the preferred GLP 1 medicine covered for obesity on its template formularies AstraZeneca scraps another GLP 1 candidate against type 2 diabetes